O2h Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Enedra Therapeuticsenedratx.cominMay 2025
Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data.
AI & Machine LearningBiotechMedical Devices
Co-investorsDeep Science VenturesKU Leuven Research & Development
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.